Andreessen Marc L: insider trades.
Andreessen Marc L reported 12 non-derivative transactions on 8 SEC ownership filings in Q3 2026: 2 open-market purchases ($24.8M) and 6 sales ($4.1M), across 5 companies.
- Transactions
- 12
- Purchases (P)
- 2
- Sales (S)
- 6
- Companies
- 5
- Name as filed
- Andreessen Marc L
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Meta Platforms, Inc. (META) | Director | 4 |
| Scribe Therapeutics, Inc. (SCTX) | TenPercentOwner | 3 |
| Coinbase Global, Inc. (COIN) | Director | 2 |
| Braveheart Bio, Inc. (BRVE) | TenPercentOwner | 2 |
| Samsara Inc. (IOT) | Director | 1 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-21 | Coinbase Global, Inc. | S | 6,838 | $205.05 | 1,129,486 | Form 4 |
| 2026-09-08 | Coinbase Global, Inc. | S | 13,676 | $181.14 | 1,136,324 | Form 4 |
| 2026-08-07 | Braveheart Bio, Inc. | P | 1,100,000 | $18 | 10,232,420 | Form 4 |
| 2026-08-07 | Braveheart Bio, Inc. | C | 9,132,420 | — | 9,132,420 | Form 4 |
| 2026-08-04 | Meta Platforms, Inc. | S | 250 | $588.16 | 176 | Form 4 |
| 2026-08-04 | Meta Platforms, Inc. | S | 87 | $589.24 | 89 | Form 4 |
| 2026-08-04 | Meta Platforms, Inc. | S | 45 | $591.69 | 0 | Form 4 |
| 2026-08-04 | Meta Platforms, Inc. | S | 44 | $590.39 | 45 | Form 4 |
| 2026-07-27 | Scribe Therapeutics, Inc. | P | 333,333 | $15 | 2,385,075 | Form 4 |
| 2026-07-27 | Scribe Therapeutics, Inc. | C | 697,650 | — | 697,650 | Form 4 |
| 2026-07-27 | Scribe Therapeutics, Inc. | C | 2,051,742 | — | 2,051,742 | Form 4 |
| 2026-07-22 | Samsara Inc. | A | 7,801 | $0 | 7,801 | Form 4 |
Questions
What stock did Andreessen Marc L buy or sell?
Andreessen Marc L reported 12 non-derivative transactions on 8 SEC ownership filings in Q3 2026: 2 open-market purchases ($24.8M) and 6 sales ($4.1M), across 5 companies.
Is Andreessen Marc L the same person as other filers with this name?
This page covers SEC CIK 1160077 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/andreessen-marc-l-1160077.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.